For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of Tafamidis and Tafamidis meglumine represents a true breakthrough . These groundbreaking therapies stabilize the transthyretin protein, preventing its harmful build-up and alleviating the impact of the condition . Patients are now experienc